IN2014DN09091A - - Google Patents

Info

Publication number
IN2014DN09091A
IN2014DN09091A IN9091DEN2014A IN2014DN09091A IN 2014DN09091 A IN2014DN09091 A IN 2014DN09091A IN 9091DEN2014 A IN9091DEN2014 A IN 9091DEN2014A IN 2014DN09091 A IN2014DN09091 A IN 2014DN09091A
Authority
IN
India
Prior art keywords
oral formulation
substrate
water
gelling agent
sugar alcohol
Prior art date
Application number
Inventor
Taro Iwamoto
Nobuyuki Kurahashi
Yoshikazu Oka
Chikako Takeda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of IN2014DN09091A publication Critical patent/IN2014DN09091A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Abstract

Provided are an oral formulation capable of improving easy administrability and showing good preservation stability and a substrate for oral formulation. An oral formulation containing a medicament; sugar alcohol; one or more kinds of hydrophilic polysaccharides selected from the group consisting of acacia pullulan and maltodextrin; a gelling agent; and water and a substrate for oral formulation which contains sugar alcohol; the above mentioned hydrophilic polysaccharides; a gelling agent; and water.
IN9091DEN2014 2012-04-30 2013-04-30 IN2014DN09091A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261640474P 2012-04-30 2012-04-30
US201361783163P 2013-03-14 2013-03-14
PCT/JP2013/062985 WO2013165021A1 (en) 2012-04-30 2013-04-30 Oral formulation

Publications (1)

Publication Number Publication Date
IN2014DN09091A true IN2014DN09091A (en) 2015-05-22

Family

ID=48483123

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9091DEN2014 IN2014DN09091A (en) 2012-04-30 2013-04-30

Country Status (21)

Country Link
US (3) US20150126521A1 (en)
EP (1) EP2844232A1 (en)
JP (1) JP6360795B2 (en)
KR (1) KR20150003898A (en)
CN (1) CN104271120A (en)
AR (1) AR091349A1 (en)
AU (1) AU2013255256B2 (en)
BR (1) BR112014026879A2 (en)
CA (1) CA2872004A1 (en)
CO (1) CO7151505A2 (en)
EA (1) EA026187B1 (en)
HK (1) HK1207290A1 (en)
IL (1) IL235111A0 (en)
IN (1) IN2014DN09091A (en)
MX (1) MX2014013155A (en)
NZ (1) NZ630029A (en)
PH (1) PH12014502323A1 (en)
SG (2) SG10201608954UA (en)
TW (1) TWI594765B (en)
WO (1) WO2013165021A1 (en)
ZA (1) ZA201408114B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498556A (en) * 2017-09-15 2019-03-22 万特制药(海南)有限公司 Aripiprazole oral solution and preparation method thereof
US11654108B1 (en) 2022-05-02 2023-05-23 Medicated Chews, Llc Sennoside medicated chews

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517886B1 (en) * 1997-06-24 2003-02-11 Biovail Corporation International Positive hydration method of preparing confectionery and the resulting product
AUPQ970300A0 (en) * 2000-08-29 2000-09-21 Massa Nominees Pty Ltd Advanced wireless network
FR2822644B1 (en) * 2001-03-30 2005-03-11 Roquette Freres SUGAR CONFECTIONERY
JP2004099558A (en) * 2002-09-11 2004-04-02 Medorekkusu:Kk Jelly formulation for pharmaceutical use
JP4547994B2 (en) * 2004-06-02 2010-09-22 救急薬品工業株式会社 Method for producing lump film-containing edible oral dosage form and lump film-containing edible oral dosage form
JP4315393B2 (en) 2005-04-14 2009-08-19 大塚製薬株式会社 Heterocyclic compounds
EP2095812A4 (en) * 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co Granular preparation prevented from caking
AU2008237246B2 (en) * 2007-04-05 2014-06-05 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
GB0818472D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
WO2010116385A2 (en) * 2009-04-08 2010-10-14 Rubicon Research Private Limited Pharmaceutical compositions for alleviating unpleasant taste
KR101074271B1 (en) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 Fast dissolving oral dosage form containing steviosides as a taste masking agent
US20110139164A1 (en) * 2009-12-15 2011-06-16 R. J. Reynolds Tobacco Company Tobacco Product And Method For Manufacture
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
JP5611672B2 (en) * 2010-05-28 2014-10-22 ゼリア新薬工業株式会社 Oral jelly
US9511022B2 (en) * 2010-08-24 2016-12-06 Otsuka Pharmaceutical Co., Ltd. Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
GB201016900D0 (en) * 2010-10-06 2010-11-17 Probio Asa Emulsion
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole

Also Published As

Publication number Publication date
AR091349A1 (en) 2015-01-28
EA201491995A1 (en) 2015-02-27
SG10201608954UA (en) 2016-12-29
ZA201408114B (en) 2016-08-31
KR20150003898A (en) 2015-01-09
CN104271120A (en) 2015-01-07
MX2014013155A (en) 2015-05-08
CA2872004A1 (en) 2013-11-07
SG11201406261QA (en) 2014-11-27
NZ630029A (en) 2016-05-27
US20180055840A1 (en) 2018-03-01
WO2013165021A1 (en) 2013-11-07
AU2013255256A1 (en) 2014-10-30
AU2013255256B2 (en) 2017-09-07
EA026187B1 (en) 2017-03-31
TWI594765B (en) 2017-08-11
TW201347773A (en) 2013-12-01
JP6360795B2 (en) 2018-07-18
US20170202833A1 (en) 2017-07-20
BR112014026879A2 (en) 2017-06-27
JP2015515959A (en) 2015-06-04
CO7151505A2 (en) 2014-12-29
AU2013255256A2 (en) 2014-11-13
US20150126521A1 (en) 2015-05-07
IL235111A0 (en) 2014-12-31
EP2844232A1 (en) 2015-03-11
PH12014502323A1 (en) 2015-01-12
HK1207290A1 (en) 2016-01-29

Similar Documents

Publication Publication Date Title
CA2956871C (en) Compounds active towards bromodomains
WO2014039903A3 (en) Stable aqueous formulations of adalimumab
EP3111931A4 (en) Pharmaceutical composition for cancer treatment containing gossypol and phenformin as active ingredients
CL2014001829A1 (en) Compounds derived from indolizine; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer.
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
MX2016008448A (en) Var2csa-drug conjugates.
DK3175711T3 (en) PARASITIC COMPOSITIONS CONTAINING MULTIPLE ACTIVE SUBSTANCES, PROCEDURES AND USES
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2014144295A8 (en) Ceftolozane antibiotic compositions
EP3151923A4 (en) Clear compositions and methods for the delivery of active ingredients for skin care
RS54588B1 (en) Liquid nasal spray containing low-dose naltrexone
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
MX343035B (en) Novel pharmaceutical formulation comprising nsaid and cyclodextrin.
UA110979C2 (en) Liquid pharmaceutical formulation comprising nitisinone
EP3177271A4 (en) Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
MX2013013649A (en) Quinone compounds for treating ape1 mediated diseases.
WO2011130692A3 (en) Androgen induced oxidative stress inhibitors
PH12014502323A1 (en) Oral formulation
TR200909786A1 (en) Effervescent tablet and granule formulation containing cefixime.
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
MX2015015537A (en) Nicotine lozenge formulation.
IT1399492B1 (en) EFFERVESCENT PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCISTEIN.